Overview
The purpose of the study is to characterize the clinical course of homocystinuria in pediatric and adult patients aged 1 to 65 years under current clinical management practices
Eligibility
Inclusion Criteria:
- Patients who are clinically diagnosed with homocystinuria
- Male/female patients aged 1 to 65 years
- Patients who consented and/or assented
- Patients who are willing and able to comply with all study-related procedures.
Exclusion Criteria:
- Medically significant postnatal complications or congenital anomalies that are not associated with homocystinuria
- Received any experimental therapy for homocystinuria during the 6 months prior to enrollment or expected to receive any such therapy during duration of the study